½ÃÀ庸°í¼­
»óǰÄÚµå
1573226

È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå : À¯Çü, Àα¸Åë°è, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Chemotherapy Chair Market by Type (Electric, Hydraulic, Manual), Demographics (Adult, Geriatric, Pediatric), End-Users - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

2023³â È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð´Â 4¾ï 4,415¸¸ ´Þ·¯·Î 2024³â¿¡´Â 4¾ï 7,146¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 6.46% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 8,840¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå¿¡´Â È­Çпä¹ý¿ë ÀÇÀÚÀÇ ¼³°è, Á¦Á¶ ¹× ÆÇ¸Å°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ÀÇÀÚ´Â Àå½Ã°£ È­Çпä¹ýÀ» ¹Þ´Â ȯÀÚ¿¡°Ô Æí¾ÈÇÔ°ú ÁöÁö·ÂÀ» Á¦°øÇϱ⠶§¹®¿¡ ÀÇ·á ȯ°æ¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ±× ¿ëµµ´Â º´¿ø, Àü¹® Ŭ¸®´Ð, ¿Ü·¡ ȯÀÚ ½Ã¼³¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, Àç¹ß Ä¡·á°¡ ÇÊ¿äÇÑ ¾Ï ȯÀÚÀÇ Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§¿¡´Â ÁÖ·Î ÀÇ·á ±â°üÀÌ Æ÷ÇԵǸç, ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ÀÎü°øÇÐÀûÀÌ°í ¾ÈÀüÇÑ ±âÁØÀ» ÃæÁ·Çϵµ·Ï ¼³°èµÈ °íǰÁúÀÇ ³»±¸¼º ÀÖ´Â ÀÇÀÚ°¡ ¿ä±¸µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 4¾ï 4,415¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 4¾ï 7,146¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 6¾ï 8,840¸¸ ´Þ·¯
CAGR(%) 6.46%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é, ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü°ú Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡°¡ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ Æí¾ÈÇÔ°ú ÀÇ·á È¿À²¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀüÀÚ½Ä Á¶Àý ±â´É ¹× ÀÇ·á¿ë Æ÷Æ® ÅëÇÕ°ú °°Àº ±â´ÉÀ» °®Ãá ±â¼úÀûÀ¸·Î Áøº¸µÈ ÀÇÀÚ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾Æ¿Í ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÈï ½ÃÀåÀº ÀÇ·áºñ Áõ°¡¿Í ¾Ï¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº Àú·ÅÇÑ °¡°Ý°ú ¸ÂÃãÈ­¸¦ Áß½ÃÇÏ´Â À̵é Áö¿ª¿¡¼­ ¼öÀÍÀ» âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë°ú ÀçÁ¤Àû ±â¹ÝÀÌ Ãë¾àÇÑ ÀÇ·á±â°ü¿¡¼­ Á¶´ÞÇØ¾ß ÇÑ´Ù´Â Á¦¾àÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº ½ÃÀå ÁøÀÔ°ú Á¦Ç° °³¹ß °úÁ¤À» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù.

Çõ½Å°ú ¿¬±¸ °³¹ßÀÇ ±âȸ´Â È­Çпä¹ý Áß È¯ÀÚÀÇ ¹ÙÀÌÅ»À» ÃßÀûÇÏ´Â ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº µðÁöÅÐ °Ç°­ ±â¼úÀ» ÅëÇÕÇÑ ´Ù±â´É ÀÇÀÚÀÇ °³¹ß¿¡ ÀÖ½À´Ï´Ù. ģȯ°æ ¼ÒÀç¿Í Áö¼Ó°¡´É¼ºÀ» °í·ÁÇÑ µðÀÚÀÎÀº ȯ°æ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ôÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¸¦ ²ø¾îµéÀÏ ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ȯÀÚÀÇ ¼±È£µµ¸¦ ÀÌÇØÇϸé ÀÎü°øÇÐÀû ¼³°è°¡ °³¼±µÇ¾î ȯÀÚÀÇ Ã¼°¨°ú ÀÇ·á±â°üÀÇ È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϸç, ÁÖ¿ä ¾÷üµéÀº ´Ù¾çÇÑ ÇコÄÉ¾î ´ÏÁî¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¼ú Çõ½Å°ú ²÷ÀÓ¾ø´Â °³¼±À» À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ÀÌ Æ´»õ½ÃÀåÀÌÁö¸¸ ÇコÄÉ¾î »ê¾÷¿¡ ÇʼöÀûÀÎ ÀÌ ºÐ¾ßÀÇ µµÀü°úÁ¦¸¦ ±Øº¹ÇÏ°í ±Þ¼ºÀåÇÏ´Â ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ °øµ¿ ¿¬±¸¿Í ÆÄÆ®³Ê½Ê¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ȯÀÚ Ä¡·áÀÇ ÁúÀ» ³ôÀ̱â À§ÇÑ ÀÇ·áºñ ÁöÃâ Áõ°¡ ¹× ÀÎÇÁ¶ó ±¸Ãà
    • È­Çпä¹ý Ä¡·á Áß È¯ÀÚ ÆíÀǼº Çâ»ó ¹× Ä¡·áÀÇ Á߿伺 Áõ´ë
    • Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡¿Í ÇÔ²² µðÀÚÀÎÀûÀÌ°í Æí¾ÈÇÑ È­Çпä¹ý¿ë ÀÇÀÚÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • °í±Þ È­Çпä¹ý¿ë ÀÇÀÚÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • È­Çпä¹ý¿ë ÀÇÀÚ¿¡ ¿ø°ÝÀÇ·á ±â¼ú ¹× ÷´Ü ȯÀÚ ¸ð´ÏÅ͸µ ±â¼ú ÅëÇÕ
    • ÇʼöÀûÀÎ ±â´É°ú ÆíÀǼºÀ» °®Ãá °¡¼ººñ ³ôÀº °íǰÁú ¸ðµ¨ÀÇ Àúºñ¿ë °³¹ß
  • ½ÃÀå °úÁ¦
    • º¹ÀâÇÑ ±ÔÁ¦ Áؼö ¹× ½ÂÀÎ ÇÁ·Î¼¼½º¿Í Ä¡¿­ÇÑ °æÀï »óȲ

Porter's Five Forces : È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : È­ÇÐÄ¡·á¿ë ÀÇÀÚ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Ù

È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå : À¯Çüº°

  • Àü±â
  • À¯¾Ð½Ä
  • ¼öµ¿

Á¦7Àå È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå : Àα¸Åë°èº°

  • ¼ºÀοë
  • ³ë³âº´
  • ¼Ò¾Æ°ú

Á¦8Àå È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ È­Çпä¹ý¿ë ÀÇÀÚ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È
ksm 24.10.25

The Chemotherapy Chair Market was valued at USD 444.15 million in 2023, expected to reach USD 471.46 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 688.40 million by 2030.

The scope of the chemotherapy chair market encompasses the design, production, and sale of chairs specifically meant for use in administering chemotherapy treatments. These chairs are essential in healthcare settings as they provide comfort and support to patients undergoing prolonged chemotherapy sessions, often lasting many hours. Their application extends across hospitals, specialty clinics, and outpatient facilities, catering largely to the growing number of cancer patients needing recurrent treatments. The end-use scope primarily includes healthcare institutions which demand high-quality, durable chairs designed to meet ergonomic and safety standards for both the patient and the healthcare provider.

KEY MARKET STATISTICS
Base Year [2023] USD 444.15 million
Estimated Year [2024] USD 471.46 million
Forecast Year [2030] USD 688.40 million
CAGR (%) 6.46%

Market insights reveal that advancements in healthcare infrastructure and the rising prevalence of cancer globally are significant growth drivers. The focus on patient comfort and healthcare efficiency fuels demand for technologically advanced chairs equipped with features such as electronic adjustability and integrated medical ports. Emerging markets in Asia and Latin America present opportunities due to increasing healthcare spending and cancer awareness. Companies can capitalize on these regions by focusing on affordability and customization. However, limitations such as high initial costs and procurement in less financially robust clinics pose challenges. Additionally, stringent regulatory standards can slow market entry or product development processes.

Innovation and research opportunities lie in the development of multifunctional chairs that integrate digital health technologies like monitoring systems to track patient vitals during chemotherapy. Eco-friendly materials and designs catering to sustainability could also attract environmentally conscious healthcare providers. Understanding patient preferences through data analytics can lead to improved ergonomic designs, enhancing patient experience and institutional efficiency. The market is competitive, with key players vying to innovate and meet varying healthcare needs, driving constant improvement. Companies should focus on research collaborations and partnerships to navigate challenges and leverage burgeoning opportunities within this niche yet essential segment of the healthcare industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chemotherapy Chair Market

The Chemotherapy Chair Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing healthcare expenditure and infrastructure development to enhance the quality of patient care
    • Growing emphasis on improving patient comfort and care during chemotherapy treatments
    • Rising prevalence of cancer globally and the need for well-designed and comfortable chemotherapy chairs
  • Market Restraints
    • High cost of advanced chemotherapy chairs
  • Market Opportunities
    • Integration of telehealth and advanced patient monitoring technologies into chemotherapy chairs
    • Development of cost-effective, high-quality models with essential features and comfort at a lower cost
  • Market Challenges
    • Complex regulatory compliance and approval processes with an intense competitive landscape

Porter's Five Forces: A Strategic Tool for Navigating the Chemotherapy Chair Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chemotherapy Chair Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chemotherapy Chair Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chemotherapy Chair Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chemotherapy Chair Market

A detailed market share analysis in the Chemotherapy Chair Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chemotherapy Chair Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chemotherapy Chair Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chemotherapy Chair Market

A strategic analysis of the Chemotherapy Chair Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chemotherapy Chair Market, highlighting leading vendors and their innovative profiles. These include ABCO Health Care Pty Ltd, Bionic Medizintechnik GmbH, BMB Medical LLC., CAMELOT FURNITURE LIMITED, Champion Manufacturing Inc., Digiterm Ltd., EarthLite, LLC., Fast Company & Inc., Favero Health Projects Spa., Fresenius Medical Care AG, GREINER GmbH, Health Tec Medical Ltd., HONG KONG MEDI CO LIMITED., IBIOM Instruments Ltee/Ltd., Lemi MD, Likamed GmbH, NanNing Passion Medical Equipment Co.,Ltd, Ocura Healthcare Ltd,, PARAMOUNT BED CO., LTD., Praticdose, Cima and Adhesia Equipements., REMI ELEKTROTECHNIK LIMITED, Score BV, Techno CC, and Zhangjiagang Medi Medical Equipment Co.,ltd..

Market Segmentation & Coverage

This research report categorizes the Chemotherapy Chair Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electric, Hydraulic, and Manual.
  • Based on Demographics, market is studied across Adult, Geriatric, and Pediatric.
  • Based on End-Users, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing healthcare expenditure and infrastructure development to enhance the quality of patient care
      • 5.1.1.2. Growing emphasis on improving patient comfort and care during chemotherapy treatments
      • 5.1.1.3. Rising prevalence of cancer globally and the need for well-designed and comfortable chemotherapy chairs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced chemotherapy chairs
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of telehealth and advanced patient monitoring technologies into chemotherapy chairs
      • 5.1.3.2. Development of cost-effective, high-quality models with essential features and comfort at a lower cost
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory compliance and approval processes with an intense competitive landscape
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of electric chemotherapy chairs owing to the enhanced comfort
    • 5.2.2. End users: Rising demand for chemotherapy chairs in specialty clinics to offer flexibility, ergonomic support
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chemotherapy Chair Market, by Type

  • 6.1. Introduction
  • 6.2. Electric
  • 6.3. Hydraulic
  • 6.4. Manual

7. Chemotherapy Chair Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Chemotherapy Chair Market, by End-Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Chemotherapy Chair Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Chemotherapy Chair Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Chemotherapy Chair Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Digiterm unveils versatile Comfort-1 Eco Chair for diverse healthcare applications
    • 12.3.2. AstraZeneca acquires Fusion Pharmaceuticals for USD 2.4 Billion to revolutionize cancer treatment with advanced radioconjugates
    • 12.3.3. Curry Health Network secures USD 2 million federal grant to enhance local healthcare with new chemotherapy facility
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABCO Health Care Pty Ltd
  • 2. Bionic Medizintechnik GmbH
  • 3. BMB Medical LLC.
  • 4. CAMELOT FURNITURE LIMITED
  • 5. Champion Manufacturing Inc.
  • 6. Digiterm Ltd.
  • 7. EarthLite, LLC.
  • 8. Fast Company & Inc.
  • 9. Favero Health Projects Spa.
  • 10. Fresenius Medical Care AG
  • 11. GREINER GmbH
  • 12. Health Tec Medical Ltd.
  • 13. HONG KONG MEDI CO LIMITED.
  • 14. IBIOM Instruments Ltee/Ltd.
  • 15. Lemi MD
  • 16. Likamed GmbH
  • 17. NanNing Passion Medical Equipment Co.,Ltd
  • 18. Ocura Healthcare Ltd,
  • 19. PARAMOUNT BED CO., LTD.
  • 20. Praticdose, Cima and Adhesia Equipements.
  • 21. REMI ELEKTROTECHNIK LIMITED
  • 22. Score BV
  • 23. Techno CC
  • 24. Zhangjiagang Medi Medical Equipment Co.,ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦